Eligibility and Projected Benefits of Rapid Initiation of Quadruple Medical Therapy for Newly Diagnosed Heart Failure

By sjmartinez • April 11, 2024

Greene SJ, Ayodele I, Pierce JB, Khan MS, Lewsey SC, Yancy CW, Alhanti B, Van Spall HGC, Allen LA, Fonarow GC. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Medical Therapy for Newly Diagnosed Heart Failure. JACC Heart Fail. 2024 Mar 25:S2213-1779(24)00244-0. doi: 10.1016/j.jchf.2024.03.001. Epub ahead of print. PMID: 38597866.

Tags: Cardiology/Epi, heart failure, Hospitalization, medication, Publications, quadruple therapy

Advancements in Artificial Intelligence for Enhanced Diagnosis and Prognosis in Cardiac CT: a Comprehensive Review and Future Perspectives

Adabifirouzjaei F, Budoff M, Nomeli M. Advancements in Artificial Intelligence for Enhanced Diagnosis and Prognosis in Cardiac CT: a Comprehensive Review and Future Perspectives. Curr[...]

Patient Communication and Radiation Safety in [177Lu]Lu-PSMA Radiopharmaceutical Therapy: International Survey of 102 Theranostic Centers

Zahner J, Unterrainer LM, Czernin J, Calais J, Eiber M, Fendler WP, Werner RA, Gardner L, Allen-Auerbach M, Benz MR. Patient Communication and Radiation Safety[...]

Metabolic Niches: MALDI Imaging Reveals Lipidomic Heterogeneity in the Human Heart

Osumi KM, Kransdorf EP, Manzoor D, Karlstaedt A, Neumann EK. Metabolic Niches: MALDI Imaging Reveals Lipidomic Heterogeneity in the Human Heart. J Am Soc Mass[...]